Beyond base pairs to bedside: A population perspective on how genomics can improve health

American Journal of Public Health

Volumn 102, Issue 1, 2012, Pages 34-37

  Khoury, Muin J ^a   Gwinn, Marta ^a   Bowen, M Scott ^a   Dotson, W David ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENOMICS; HEALTH CARE DELIVERY; HEALTH STATUS; HUMAN; ORGANIZATION AND MANAGEMENT; TRANSLATIONAL RESEARCH;

DELIVERY OF HEALTH CARE; GENOMICS; HEALTH STATUS; HUMANS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84857267425     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2011.300299     Document Type: Review

References (38)

1. Green ED, Guyer MS, National Human Genome Research Institute. Charting a course for genomic medicine from base pairs to bedside. Nature. 2011; 470(7333):204-213.
2. Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, Bradley L. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med. 2007; 9(10):665-674. (Pubitemid 350287151)
3. Sung NS, Crowley WFJr, Genel M, et al. Central challenges facing the national clinical research enterprise. JAMA. 2003; 289(10):1278-1287. (Pubitemid 37432909)
4. Leischow SJ, Best A, Trochim WM, et al. Systems thinking to improve the public's health. Am J Prev Med. 2008; 35(2)(suppl):S196-S203. (Pubitemid 351932077)
5. Thomas JC, Sage M, Dillenberg J, Gillory VJ. A code of ethics for public health. Am J Public Health. 2002;92(7): 1057-1059. (Pubitemid 34700960)
6. Thomas JC, Irwin DE, Zuiker ES, Millikan RC. Genomics and the public health code of ethics. Am J Public Health. 2005;95(12):2139-2143. (Pubitemid 41740243)
7. Khoury MJ, Bowen MS, Burke W, et al. Current priorities in public health practice in addressing the role of human genomics in improving population health. Am J Prev Med. 2011;40(4):486-493.
8. Hall WD, Matthews R, Morley KI. Being more realistic about the public health impact of genomic medicine. PLoS Med. 2010;7(10):e1000347.
9. Burke W, Burton H, Hall AE, et al. Extending the reach of public health genomics: what should be the agenda for public health in an era of genome-based and personalized medicine? Genet Med. 2010;12(12):785-791.
10. O'Leary P, Zimmern RL. Genomics and public health: translating research into public benefit. Public Health Genomics. 2010;13(4):193-196.
11. Chang MH, Lindegren ML, Butler MA, et al. Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994. Am J Epidemiol. 2009;169(1):54-66.
12. Kindig D, Stoddart G. What is population health? Am J Public Health. 2003;93(3):380-383. (Pubitemid 36255173)
13. Institute of Medicine. Genes, Behavior and the Social Environment: Moving Beyond the Nature/Nurture Debate. Washington, DC: National Academies Press; 2006.
14. Mathers JC, McKay JA. Epigenetics-potential contributions to fetal programming. Adv Exp Med Biol. 2009;646: 119-123.
15. Phenotypes and Endophenotypes: Foundations for Genetic Studies of Nicotine Use and Dependence. Bethesda, MD: National Cancer Institute; 2009.
16. Travis LB, Beard C, Allan JM, et al. Testicular cancer survivorship: research strategies and recommendations. J Natl Cancer Inst. 2010;102(15):1114-1130.
17. Khoury MJ, Davis RL, Gwinn M, Lindegren ML, Yoon P. Do we need genomic research for the prevention of common diseases with environmental causes? Am J Epidemiol. 2005;161(9): 799-805. (Pubitemid 40577833)
18. Galea S, Riddle M, Kaplan GA. Causal thinking and complex system approaches in epidemiology. Int J Epidemiol. 2010; 39(1):97-106.
19. Davey Smith G. Mendelian randomization for strengthening causal inference in observational studies: applications to gene · environment interactions. Perspect Psychol Sci. 2010;5(5):527-545.
20. Christiani DC, Mehta AJ, Yu CL. Genetic susceptibility to occupational exposures. Occup Environ Med. 2008;65(6): 430-436. (Pubitemid 351775807)
21. Schully SD, Benedicto CB, Gillanders EM, Wang SS, Khoury MJ. Translational research in cancer genetics: the road less traveled. Public Health Genomics. 2011; 14(1):1-8.
22. Usdin S. Translation under one roof. Sci Bus Exch. 2010;3(48):doi:10. 1038/scibx.2010.1430.
23. Buchanan AV, Weiss KM, Fullerton SM. Dissecting complex disease: the quest for the philosopher's stone? Int J Epidemiol. 2006;35(3):562-571. (Pubitemid 43985537)
24. Nelson HD, Huffman LH, Fu R, Harris EL, U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2005; 143(5):362-379.
25. Armstrong K, Micco E, Carney A, Stopfer J, Putt M. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA. 2005;293(14):1729-1736.
26. Bellcross CA, Kolor KK, Goddard KA, Coates RJ, Reyes M, Khoury MJ. Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians. Am J Prev Med. 2011;40(1):61-66.
27. Phillips KA. Closing the evidence gap in the use of emerging testing technologies in clinical practice. JAMA. 2008; 300(21):2542-2544.
28. National Center for Biotechnology Information. GeneTests. Available at: http://www.ncbi.nlm.nih.gov/sites/GeneTests/?db=GeneTests. Accessed February 1, 2011.
29. Gwinn M, Grossnicklaus DA, Yu W, et al. Horizon scanning for new genomic tests. Genet Med. 2011;13(2):161-165.
30. Ashley EA, Butte AJ, Wheeler MT, et al. Clinical assessment incorporating a personal genome. Lancet. 2010; 375(9725):1525-1535.
31. Bloss CS, Schork NJ, Topol EJ. Effect of direct-to-consumer genomewide profiling to assess disease risk. N Engl J Med. 2011;364(6):524-534.
32. Khoury MJ, McBride CM, Schully SD, et al. The scientific foundation for personal genomics: recommendations from a National Institutes of Health- Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med. 2009;11(8):559-567.
33. Lloyd-Puryear MA, Brower A. Longterm follow up after newborn screening: a systems approach for improving health outcomes. Genet Med. 2010; 12(12)(suppl):S256-S260.
34. Khoury MJ, Berg A, Coates RC, Evans J, Teutsch SM, Bradley LA. The evidence dilemma in genomic medicine. Health Aff (Millwood). 2008;27(6):1600-1611.
35. Khoury MJ. Dealing with the evidence dilemma in genomics and personalized medicine. Clin Pharmacol Ther. 2010;87(6):635-638.
36. Veenstra DL, Roth JA, Garrison LP Jr, Ramsey SD, Burke W. A formal risk- benefit framework for genomic tests: facilitating the appropriate translation of genomics into clinical practice. Genet Med. 2010;12(11):686-693.
37. Garber AM, Tunis SR. Does comparative effectiveness research threaten personalized medicine? N Engl J Med. 2009;360(19):1925-1927.
38. McBride CM, Bowen D, Brody LC, et al. Future health applications of genomics: priorities for communication, behavioral, and social sciences research. Am J Prev Med. 2010;38(5):556-565.